| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |